Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
JMJD5 likely encodes a histone lysine demethylase. Additionally we are shipping Jumonji Domain Containing 5 Proteins (10) and many more products for this protein.
Showing 10 out of 63 products:
Human Polyclonal JMJD5 Primary Antibody for EIA, WB - ABIN952977
Hsia, Tepper, Pochampalli, Hsia, Izumiya, Huerta, Wright, Chen, Kung, Izumiya: KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. in Proceedings of the National Academy of Sciences of the United States of America 2010
Show all 3 references for ABIN952977
Human Polyclonal JMJD5 Primary Antibody for WB - ABIN654939
Shi: Histone lysine demethylases: emerging roles in development, physiology and disease. in Nature reviews. Genetics 2007
Show all 3 references for ABIN654939
Human Polyclonal JMJD5 Primary Antibody for EIA, IHC (p) - ABIN500086
Takeuchi, Watanabe, Takano-Shimizu, Kondo: Roles of jumonji and jumonji family genes in chromatin regulation and development. in Developmental dynamics : an official publication of the American Association of Anatomists 2006
Data suggest that JMJD5 partially accumulates on mitotic spindles during mitosis; depletion of JMJD5 results in significant mitotic arrest, spindle assembly defects, and sustained activation of spindle assembly checkpoint.
These results suggest that direct interaction of JMJD5 with HBx facilitates hepatitis B virus replication through the hydroxylase activity of JMJD5.
Suggest JMJD5 as a potential oncogene (show RAB1A Antibodies) in colon carcinogenesis.
results reveal that JMJD5 is a novel binding partner of p53 (show TP53 Antibodies) and it functions as a positive modulator of cell cycle and cell proliferation mainly through the repression of p53 (show TP53 Antibodies) pathway.
we provide genetic and biochemical evidence that the JMJD5/CDKN1A (p21 (show CDKN1A Antibodies)) axis is essential to maintaining the short G1 phase which is critical for pluripotency in human embryonic stem cells
RCCD1 and KDM8 form a histone demethylase (show MBD2 Antibodies) complex.
These results reveal that the N-terminal domain is essential for the nuclear localization of JMJD5 and its normal enzymatic function towards substrates in the nucleus
Comparison of the structure of JMJD5 with that of FIH (show CASR Antibodies), a well characterized protein hydroxylase, reveals that human JMJD5 might function as a protein hydroxylase.
JMJD5 has a role in regulating PKM2 nuclear translocation and reprogramming HIF-1alpha (show HIF1A Antibodies)-mediated glucose metabolism
The study reports high-resolution crystal structures of the human JMJD5 catalytic domain in complex with the substrate 2-oxoglutarate (2-OG) and the inhibitor N-oxalylglycine (NOG (show NOG Antibodies)).
Data suggest that Jmjd5 partially accumulates on mitotic spindles during mitosis; depletion of Jmjd5 results in significant mitotic arrest, spindle assembly defects, and sustained activation of spindle assembly checkpoint.
Collectively, these data indicate that JMJD5 is essential during embryonal development and a repressor of p53 (show TP53 Antibodies) expression. The latter suggests that JMJD5 has oncogenic activity and accordingly JMJD5 is upregulated in leukemias and breast cancer.
Results suggest that Jmjd5 physiologically moderates embryonic cell proliferation through the epigenetic control of Cdkn1a (show CDKN1A Antibodies) expression.
This gene likely encodes a histone lysine demethylase. Studies of a similar protein in mouse indicate a potential role for this protein as a tumor suppressor. Alternatively spliced transcript variants have been described.
jumonji domain containing 5
, JmjC domain-containing protein 5
, Jumonji domain-containing protein 5
, lysine-specific demethylase 8
, jmjC domain-containing protein 5
, jumonji domain-containing protein 5